UB Paderborn / Katalog / Suche / in CDI

1 – 9 von 9

Sortiert nach

Ondansentron and dexamethasone treatment with different dosing schedules (24 versus 32 mg) in patients with non-small-cell lung cancer under cisplatin-based chemotherapy: A randomized study

Chemotherapy (Basel), 2000-09, Vol.46 (5), p.364-370

2000

Volltextzugriff (PDF)

Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide

Kidney international, 2000-01, Vol.57 (1), p.258-264

2000

Volltextzugriff (PDF)

Autoimmunity and autoimmune disease

Nephrology, dialysis, transplantation, 2001-01, Vol.16 (suppl-6), p.48-51

2001

Volltextzugriff (PDF)

Toward Health-Centered Monitoring framework promoting Well-Being and Nature-based Solutions

Proceedings of the 17th International Conference on PErvasive Technologies Related to Assistive Environments, 2024, p.435-439

2024

Volltextzugriff (PDF)

Clostridium difficile colitis associated with a ‘triple’ regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori

Journal of internal medicine, 1998-03, Vol.243 (3), p.251-253

1998

Volltextzugriff (PDF)

Quantifying the Impact of Nature based Interventions on Citizen Health and Well-being

Proceedings of the 17th International Conference on PErvasive Technologies Related to Assistive Environments, 2024, p.428-434

2024

Volltextzugriff (PDF)

Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study

Journal of experimental & clinical cancer research, 2001-03, Vol.20 (1), p.29

2001

Volltextzugriff (PDF)

Breast cancer (BC) after curative chemotherapy (CT) in non-hodgkin's lymphoma (NHL): drug resistance as the major cause of treatment failure

European journal of cancer (1990), 1999-09, Vol.35, p.S196-S196

1999

Volltextzugriff (PDF)

Ondansentron and Dexamethasone Treatment with Different Dosing Schedules (24 versus 32 mg) in Patients with Non-Small-Cell Lung Cancer under Cisplatin-Based Chemotherapy:A Randomized Stud y

Chemotherapy (Basel), 2000-10, Vol.46 (5), p.364-370

2000

Volltextzugriff (PDF)

1 – 9 von 9

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7)
Mit Volltextzugriff
(8)

Publikationsform

Artikel
(7)
Tagungsberichte
(2)

Sprache

Englisch
(9)

Erscheinungsjahr

n.n

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Ondansentron and dexamethasone treatment with different dosing schedules (24 versus 32 mg) in patients with non-small-cell lung cancer under cisplatin-based chemotherapy: A randomized study

Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide

Autoimmunity and autoimmune disease

Toward Health-Centered Monitoring framework promoting Well-Being and Nature-based Solutions

Clostridium difficile colitis associated with a ‘triple’ regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori

Quantifying the Impact of Nature based Interventions on Citizen Health and Well-being

Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study

Breast cancer (BC) after curative chemotherapy (CT) in non-hodgkin's lymphoma (NHL): drug resistance as the major cause of treatment failure

Ondansentron and Dexamethasone Treatment with Different Dosing Schedules (24 versus 32 mg) in Patients with Non-Small-Cell Lung Cancer under Cisplatin-Based Chemotherapy:A Randomized Stud y

Suchergebnisse filtern